Dexcom (DXCM) Share-based Compensation Growth (1y) (2011 - 2026)
Dexcom (DXCM) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 7.56% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 9.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.91% |
| Mar 31, 2026 | 26.61% |
| Dec 31, 2025 | -19.17% |
| Sep 30, 2025 | 3.92% |
| Jun 30, 2025 | 77.85% |
| Dec 31, 2024 | 17.34% |
| Sep 30, 2024 | 11.28% |
| Jun 30, 2024 | 12.59% |
| Mar 31, 2024 | 10.80% |
| Dec 31, 2023 | 8.53% |
| Sep 30, 2023 | 26.62% |
| Jun 30, 2023 | 21.78% |
| Mar 31, 2023 | 20.96% |
| Dec 31, 2022 | 29.28% |
| Sep 30, 2022 | -59.84% |
| Jun 30, 2022 | 6,420.00% |
| Mar 31, 2022 | 193.94% |
| Dec 31, 2021 | -22.87% |
| Sep 30, 2021 | 149.84% |
| Jun 30, 2021 | -98.37% |